Allogene Therapeutics
ALLO
ALLO
161 hedge funds and large institutions have $586M invested in Allogene Therapeutics in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 46 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
-9
Holders Change %
-5.29%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
54
Reduced
46
Closed
32
Calls
$1.28M
Puts
$260K
Net Calls
+$1.02M
Net Calls Change
+$1.38M
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$5.79M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$23.2M |
| 3 |
3
Millennium Management
New York
|
$901K |
| 4 |
4
Morgan Stanley
New York
|
$9.98M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$13.9M |
